- Kidney
- Liver
- Heart
- Lung
- Pancreas
- Others
Organ Transplantation Market size was valued at approximately USD 18,362.8 million, with projections indicating a compound annual growth rate (CAGR) of 11.2% from 2024 to 2030. The organ transplantation market encompasses surgical procedures, medical devices, pharmaceuticals, and services related to replacing damaged or failing organs with healthy organs from donors. This field has seen significant advancements in surgical techniques, immunosuppression therapies, and organ preservation methods. The market is experiencing growth due to the increasing prevalence of chronic diseases leading to organ failure, advancements in transplantation techniques, and rising awareness about organ donation.
Organ transplantation offers life-saving solutions for patients with end-stage organ failure, improving quality of life and survival rates. The kidney transplant segment dominates the market due to the high prevalence of chronic kidney disease worldwide. However, the market faces challenges such as organ shortages, high costs associated with transplantation procedures, and the risk of organ rejection. Ethical concerns and regulatory hurdles in some regions also impact market growth. To address these challenges, researchers are exploring innovative solutions such as xenotransplantation and 3D bioprinting of organs, which could potentially revolutionise the field in the coming years.
Organ Transplantation Market Key Developments:
- In June 2023, 3D BioFibR launched a bio-ink additive named μCollaFibR and CollaFibR 3D scaffold, a new collagen fibre product used to bioprinting tissue and organ models.
- In November 2021, Thermo Fisher Scientific announced the launch of two transplant diagnostics portfolios for better characterization of samples and to bring speed and confidence to the transplant laboratory. Such advancements in transplant laboratories boost market expansion.
Organ Transplantation Market Summary
Study Period
2024-2030Base Year
2023CAGR
11.2%Largest Market
North-AmericaFastest Growing Market
North-AmericaOrgan Transplantation Market Dynamics
From a technological perspective, advancements in organ preservation solutions are extending the viability of donor organs, allowing for longer transport times and potentially increasing the donor pool. Machine perfusion techniques, which maintain organs in near-physiological conditions outside the body, are showing promising results in improving graft function and reducing ischemia-reperfusion injury. The integration of artificial intelligence in organ matching algorithms is enhancing the efficiency and accuracy of donor-recipient pairing, potentially leading to better outcomes and reduced waiting times. Additionally, the emergence of ex vivo organ repair technologies is allowing for the rehabilitation of marginal organs that would have previously been discarded, thereby expanding the available organ pool. The COVID-19 pandemic initially led to a decrease in transplant procedures due to healthcare system overload and concerns about immunosuppression.
North-America Got Significant Share of
Organ Transplantation Market Regional Analysis
North America currently leads the global organ transplantation market. The region's dominance is attributed to advanced healthcare infrastructure, high healthcare spending, and well-established organ donation systems. The United States, in particular, performs the highest number of organ transplants annually worldwide, with over 39,000 transplants conducted in 2023. Europe follows closely, with countries like Spain leading in organ donation rates due to effective policies and public awareness campaigns.
The European market benefits from collaborative organ-sharing networks across countries, optimizing organ allocation and utilization. Asia Pacific is expected to witness the fastest growth during the forecast period. Countries like China and India are driving market growth through improving healthcare infrastructure, increasing awareness about organ donation, and government initiatives to promote transplantation programs. The rapid economic growth in these countries is also contributing to increased healthcare spending and improved access to transplantation services.
Latin America
Europe
Asia Pacific
Middle East
North America
Organ Transplantation Market Segmentation
By Organ Type
By Product Type
- Immunosuppressants
- Preservation Solutions
- Organ Care Systems
By End User
- Hospitals
- Transplant Centers
- Others
Frequently Asked Questions
In 2023, the global organ transplantation market was valued at approximately USD 18,362.8 million, with projections indicating a compound annual growth rate (CAGR) of 11.2% from 2024 to 2030.
The key drivers for the organ transplantation market include the increasing prevalence of chronic diseases leading to organ failure, advancements in transplantation techniques and immunosuppressive therapies, rising awareness about organ donation, and improving healthcare infrastructure in developing countries.
Key factors hindering the growth of the global organ transplantation market include persistent organ shortages, high costs associated with transplantation procedures and post-transplant care, the risk of organ rejection, ethical concerns in some regions, and regulatory challenges in emerging markets.
The key players in the organ transplantation market include Novartis AG,Teva Pharmaceutical Industries Ltd., Arthrex, Inc., Veloxis Pharmaceuticals, Inc., BioLife Solutions, TransMedics, F. Hoffmann-La Roche Ltd., Zimmer Biomet, and Astellas Pharma Inc.
Key Features of the Report
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
| 1.Executive Summary |
| 2.Global Organ Transplantation Market Introduction |
| 2.1.Global Organ Transplantation Market - Taxonomy |
| 2.2.Global Organ Transplantation Market - Definitions |
| 2.2.1.Organ Type |
| 2.2.2.Product |
| 2.2.3.End-user |
| 2.2.4.Region |
| 3.Global Organ Transplantation Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Organ Transplantation Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Organ Transplantation Market By Organ Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Kidney |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Liver |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Heart |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Lung |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Pancreas |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6.Global Organ Transplantation Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Immunosuppressants |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Preservation Solutions |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Organ Care Systems |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Organ Transplantation Market By End-user, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Transplant Centers |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Organ Transplantation Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Organ Transplantation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Organ Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Kidney |
| 9.1.2.Liver |
| 9.1.3.Heart |
| 9.1.4.Lung |
| 9.1.5.Pancreas |
| 9.1.6.Others |
| 9.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Immunosuppressants |
| 9.2.2.Preservation Solutions |
| 9.2.3.Organ Care Systems |
| 9.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Transplant Centers |
| 9.3.3.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Organ Transplantation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Organ Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Kidney |
| 10.1.2.Liver |
| 10.1.3.Heart |
| 10.1.4.Lung |
| 10.1.5.Pancreas |
| 10.1.6.Others |
| 10.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Immunosuppressants |
| 10.2.2.Preservation Solutions |
| 10.2.3.Organ Care Systems |
| 10.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Transplant Centers |
| 10.3.3.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Organ Transplantation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Organ Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Kidney |
| 11.1.2.Liver |
| 11.1.3.Heart |
| 11.1.4.Lung |
| 11.1.5.Pancreas |
| 11.1.6.Others |
| 11.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Immunosuppressants |
| 11.2.2.Preservation Solutions |
| 11.2.3.Organ Care Systems |
| 11.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Transplant Centers |
| 11.3.3.Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Organ Transplantation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Organ Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Kidney |
| 12.1.2.Liver |
| 12.1.3.Heart |
| 12.1.4.Lung |
| 12.1.5.Pancreas |
| 12.1.6.Others |
| 12.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Immunosuppressants |
| 12.2.2.Preservation Solutions |
| 12.2.3.Organ Care Systems |
| 12.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Transplant Centers |
| 12.3.3.Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Organ Transplantation Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Organ Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Kidney |
| 13.1.2.Liver |
| 13.1.3.Heart |
| 13.1.4.Lung |
| 13.1.5.Pancreas |
| 13.1.6.Others |
| 13.2. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Immunosuppressants |
| 13.2.2.Preservation Solutions |
| 13.2.3.Organ Care Systems |
| 13.3. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Transplant Centers |
| 13.3.3.Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Astellas Pharma Inc. |
| 14.2.2.Novartis AG |
| 14.2.3.Teva Pharmaceutical Industries Ltd. |
| 14.2.4.Arthrex, Inc. |
| 14.2.5.Veloxis Pharmaceuticals, Inc. |
| 14.2.6.BioLife Solutions |
| 14.2.7.TransMedics |
| 14.2.8.Hoffmann-La Roche Ltd. |
| 14.2.9.Zimmer Biomet |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Astellas Pharma Inc.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Arthrex, Inc.
- Veloxis Pharmaceuticals, Inc.
- BioLife Solutions
- TransMedics
- Hoffmann-La Roche Ltd.
- Zimmer Biomet